Multiplex secretome engineering enhances recombinant protein production and purity

Autor: Bernhard O. Palsson, Austin W. T. Chiang, Johnny Arnsdorf, Marianne Decker, Sanne Schoffelen, Tune Wulff, Lasse Ebdrup Pedersen, Helene Faustrup Kildegaard, Stefan Kol, Tanja Lyholm Jensen, Jahir M. Gutierrez, Gyun Min Lee, Bjørn G. Voldborg, Anders Holmgaard Hansen, Helen O. Masson, Daniel Ley, Nathan E. Lewis
Rok vydání: 2020
Předmět:
0106 biological sciences
0301 basic medicine
medicine.drug_class
Science
Cell
General Physics and Astronomy
CHO Cells
Biologics
Monoclonal antibody
01 natural sciences
Article
General Biochemistry
Genetics and Molecular Biology

Antibodies
03 medical and health sciences
Gene Knockout Techniques
Cricetulus
010608 biotechnology
Monoclonal
medicine
Protein biosynthesis
Computational models
Animals
Multiplex
lcsh:Science
Biological Products
Chromatography
Multidisciplinary
biology
Chemistry
Chinese hamster ovary cell
Antibodies
Monoclonal

High-Throughput Nucleotide Sequencing
General Chemistry
Recombinant Proteins
030104 developmental biology
Secretory protein
medicine.anatomical_structure
Biochemistry
Metabolic Engineering
Cell culture
biology.protein
lcsh:Q
Synthetic Biology
Antibody
Rituximab
Biotechnology
Zdroj: Nature communications, vol 11, iss 1
Nature Communications, Vol 11, Iss 1, Pp 1-10 (2020)
Kol, S, Ley, D, Wulff, T, Decker, M, Arnsdorf, J, Schoffelen, S, Hansen, A H, Jensen, T L, Gutierrez, J M, Chiang, A W T, Masson, H O, Palsson, B O, Voldborg, B G, Pedersen, L E, Kildegaard, H F, Min Lee, G & Lewis, N E 2020, ' Multiplex secretome engineering enhances recombinant protein production and purity ', Nature Communications, vol. 11, no. 1 . https://doi.org/10.1038/s41467-020-15866-w
Nature Communications
Popis: Host cell proteins (HCPs) are process-related impurities generated during biotherapeutic protein production. HCPs can be problematic if they pose a significant metabolic demand, degrade product quality, or contaminate the final product. Here, we present an effort to create a “clean” Chinese hamster ovary (CHO) cell by disrupting multiple genes to eliminate HCPs. Using a model of CHO cell protein secretion, we predict that the elimination of unnecessary HCPs could have a non-negligible impact on protein production. We analyze the HCP content of 6-protein, 11-protein, and 14-protein knockout clones. These cell lines exhibit a substantial reduction in total HCP content (40%-70%). We also observe higher productivity and improved growth characteristics in specific clones. The reduced HCP content facilitates purification of a monoclonal antibody. Thus, substantial improvements can be made in protein titer and purity through large-scale HCP deletion, providing an avenue to increased quality and affordability of high-value biopharmaceuticals.
Host cell proteins can contaminate biotherapeutics and compromise and degrade their quality. Here the authors use modelling and CRISPR to delete secreted host proteins in CHO cells, leading to improved monoclonal antibody production and purity.
Databáze: OpenAIRE